{"resourceType":"EvidenceVariable","id":"example-eligibility-criteria-ada-rec-bariatric","text":{"status":"generated","div":"\u003cdiv xmlns\u003d\"http://www.w3.org/1999/xhtml\"\u003e\u003cp\u003e\u003cb\u003eGenerated Narrative: EvidenceVariable\u003c/b\u003e\u003ca name\u003d\"example-eligibility-criteria-ada-rec-bariatric\"\u003e \u003c/a\u003e\u003c/p\u003e\u003cdiv style\u003d\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"\u003e\u003cp style\u003d\"margin-bottom: 0px\"\u003eResource EvidenceVariable \u0026quot;example-eligibility-criteria-ada-rec-bariatric\u0026quot; \u003c/p\u003e\u003c/div\u003e\u003cp\u003e\u003cb\u003eidentifier\u003c/b\u003e: FEvIR Object Identifier: 32140\u003c/p\u003e\u003cp\u003e\u003cb\u003etitle\u003c/b\u003e: RecommendationEligibilityCriteria: Eligibility Criteria for Bariatric Surgery (ADA Recommendation 8.16)\u003c/p\u003e\u003cp\u003e\u003cb\u003eshortTitle\u003c/b\u003e: Recommend bariatric surgery if BMI 35 or higher\u003c/p\u003e\u003cp\u003e\u003cb\u003estatus\u003c/b\u003e: active\u003c/p\u003e\u003cp\u003e\u003cb\u003epublisher\u003c/b\u003e: Computable Publishing LLC\u003c/p\u003e\u003cp\u003e\u003cb\u003econtact\u003c/b\u003e: \u003ca href\u003d\"mailto:support@computablepublishing.com\"\u003esupport@computablepublishing.com\u003c/a\u003e\u003c/p\u003e\u003cp\u003e\u003cb\u003edescription\u003c/b\u003e: Inclusion Criteria: [[1]] Adults. [[2]] Diagnosed with type 2 diabetes. [[3]] Body Mass Index (BMI) ≥ 40.0 kg/m2 (BMI ≥ 37.5 kg/m2 in Asian Americans), or BMI ≥ 35.0 kg/m2 and ≤ 39.9 kg/m2 (BMI 32.5-37.4 kg/m2 in Asian Americans) who do not achieve durable weight loss and improvement in comorbidities (including hyperglycemia) with nonsurgical methods. [[4]] Screened surgical candidates.\u003c/p\u003e\u003cp\u003e\u003cb\u003ecopyright\u003c/b\u003e: https://creativecommons.org/licenses/by-nc-sa/4.0/\u003c/p\u003e\u003cp\u003e\u003cb\u003eeffectivePeriod\u003c/b\u003e: 2021-01 --\u0026gt; (ongoing)\u003c/p\u003e\u003cp\u003e\u003cb\u003eauthor\u003c/b\u003e: Brian S. Alper: \u003c/p\u003e\u003cp\u003e\u003cb\u003eactual\u003c/b\u003e: false\u003c/p\u003e\u003cblockquote\u003e\u003cp\u003e\u003cb\u003echaracteristic\u003c/b\u003e\u003c/p\u003e\u003cp\u003e\u003cb\u003edescription\u003c/b\u003e: Adult.\u003c/p\u003e\u003cp\u003e\u003cb\u003eexclude\u003c/b\u003e: false\u003c/p\u003e\u003ch3\u003eDefinitionByTypeAndValues\u003c/h3\u003e\u003ctable class\u003d\"grid\"\u003e\u003ctr\u003e\u003ctd\u003e-\u003c/td\u003e\u003ctd\u003e\u003cb\u003eType\u003c/b\u003e\u003c/td\u003e\u003ctd\u003e\u003cb\u003eValue[x]\u003c/b\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd\u003e*\u003c/td\u003e\u003ctd\u003eAge \u003cspan style\u003d\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"\u003e (\u003ca href\u003d\"https://browser.ihtsdotools.org/\"\u003eSNOMED CT\u003c/a\u003e#397669002)\u003c/span\u003e\u003c/td\u003e\u003ctd\u003e\u0026gt;\u003d18 years\u003cspan style\u003d\"background: LightGoldenRodYellow\"\u003e (Details: UCUM code a \u003d \u0027a\u0027)\u003c/span\u003e\u003c/td\u003e\u003c/tr\u003e\u003c/table\u003e\u003c/blockquote\u003e\u003cblockquote\u003e\u003cp\u003e\u003cb\u003echaracteristic\u003c/b\u003e\u003c/p\u003e\u003cp\u003e\u003cb\u003edescription\u003c/b\u003e: Diagnosed with type 2 diabetes.\u003c/p\u003e\u003cp\u003e\u003cb\u003eexclude\u003c/b\u003e: false\u003c/p\u003e\u003ch3\u003eDefinitionByTypeAndValues\u003c/h3\u003e\u003ctable class\u003d\"grid\"\u003e\u003ctr\u003e\u003ctd\u003e-\u003c/td\u003e\u003ctd\u003e\u003cb\u003eType\u003c/b\u003e\u003c/td\u003e\u003ctd\u003e\u003cb\u003eValue[x]\u003c/b\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd\u003e*\u003c/td\u003e\u003ctd\u003eDisease (disorder) \u003cspan style\u003d\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"\u003e (\u003ca href\u003d\"https://browser.ihtsdotools.org/\"\u003eSNOMED CT\u003c/a\u003e#64572001; resource-types#Condition \u0026quot;Condition\u0026quot;)\u003c/span\u003e\u003c/td\u003e\u003ctd\u003eDiabetes mellitus type 2 (disorder) \u003cspan style\u003d\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"\u003e (\u003ca href\u003d\"https://browser.ihtsdotools.org/\"\u003eSNOMED CT\u003c/a\u003e#44054006)\u003c/span\u003e\u003c/td\u003e\u003c/tr\u003e\u003c/table\u003e\u003c/blockquote\u003e\u003cblockquote\u003e\u003cp\u003e\u003cb\u003echaracteristic\u003c/b\u003e\u003c/p\u003e\u003cp\u003e\u003cb\u003edescription\u003c/b\u003e: Body Mass Index (BMI) ≥ 40.0 kg/m2 (BMI ≥ 37.5 kg/m2 in Asian Americans), or BMI ≥ 35.0 kg/m2 and ≤ 39.9 kg/m2 (BMI 32.5-37.4 kg/m2 in Asian Americans) who do not achieve durable weight loss and improvement in comorbidities (including hyperglycemia) with nonsurgical methods.\u003c/p\u003e\u003cblockquote\u003e\u003cp\u003e\u003cb\u003edefinitionByCombination\u003c/b\u003e\u003c/p\u003e\u003cp\u003e\u003cb\u003ecode\u003c/b\u003e: any-of\u003c/p\u003e\u003cblockquote\u003e\u003cp\u003e\u003cb\u003echaracteristic\u003c/b\u003e\u003c/p\u003e\u003cp\u003e\u003cb\u003edescription\u003c/b\u003e: Body Mass Index (BMI) ≥ 40.0 kg/m2\u003c/p\u003e\u003cp\u003e\u003cb\u003eexclude\u003c/b\u003e: false\u003c/p\u003e\u003c/blockquote\u003e\u003cblockquote\u003e\u003cp\u003e\u003cb\u003echaracteristic\u003c/b\u003e\u003c/p\u003e\u003cp\u003e\u003cb\u003edescription\u003c/b\u003e: BMI ≥ 37.5 kg/m2 in Asian Americans\u003c/p\u003e\u003c/blockquote\u003e\u003cblockquote\u003e\u003cp\u003e\u003cb\u003echaracteristic\u003c/b\u003e\u003c/p\u003e\u003cp\u003e\u003cb\u003edescription\u003c/b\u003e: BMI ≥ 35.0 kg/m2 and ≤ 39.9 kg/m2 who do not achieve durable weight loss and improvement in comorbidities (including hyperglycemia) with nonsurgical methods.\u003c/p\u003e\u003c/blockquote\u003e\u003cblockquote\u003e\u003cp\u003e\u003cb\u003echaracteristic\u003c/b\u003e\u003c/p\u003e\u003cp\u003e\u003cb\u003edescription\u003c/b\u003e: BMI ≥ 32.5 kg/m2 and ≤ 37.4 kg/m2 in Asian Americans who do not achieve durable weight loss and improvement in comorbidities (including hyperglycemia) with nonsurgical methods.\u003c/p\u003e\u003c/blockquote\u003e\u003c/blockquote\u003e\u003c/blockquote\u003e\u003cblockquote\u003e\u003cp\u003e\u003cb\u003echaracteristic\u003c/b\u003e\u003c/p\u003e\u003cp\u003e\u003cb\u003edescription\u003c/b\u003e: Cardiovascular event (myocardial infarction, acute coronary syndrome, coronary artery angioplasty or bypass, stroke) in the past six months.\u003c/p\u003e\u003cp\u003e\u003cb\u003enote\u003c/b\u003e: placeholder for now to represent \u0027screened surgical candidate\u0027\u003c/p\u003e\u003cp\u003e\u003cb\u003eexclude\u003c/b\u003e: true\u003c/p\u003e\u003cblockquote\u003e\u003cp\u003e\u003cb\u003edefinitionByCombination\u003c/b\u003e\u003c/p\u003e\u003cp\u003e\u003cb\u003ecode\u003c/b\u003e: any-of\u003c/p\u003e\u003cblockquote\u003e\u003cp\u003e\u003cb\u003echaracteristic\u003c/b\u003e\u003c/p\u003e\u003cp\u003e\u003cb\u003edescription\u003c/b\u003e: acute coronary heart disease (a value set covering many forms)\u003c/p\u003e\u003c/blockquote\u003e\u003cblockquote\u003e\u003cp\u003e\u003cb\u003echaracteristic\u003c/b\u003e\u003c/p\u003e\u003cp\u003e\u003cb\u003edescription\u003c/b\u003e: coronary artery angioplasty or bypass\u003c/p\u003e\u003c/blockquote\u003e\u003cblockquote\u003e\u003cp\u003e\u003cb\u003echaracteristic\u003c/b\u003e\u003c/p\u003e\u003cp\u003e\u003cb\u003edescription\u003c/b\u003e: stroke\u003c/p\u003e\u003c/blockquote\u003e\u003c/blockquote\u003e\u003ch3\u003eTimeFromEvents\u003c/h3\u003e\u003ctable class\u003d\"grid\"\u003e\u003ctr\u003e\u003ctd\u003e-\u003c/td\u003e\u003ctd\u003e\u003cb\u003eDescription\u003c/b\u003e\u003c/td\u003e\u003ctd\u003e\u003cb\u003eNote\u003c/b\u003e\u003c/td\u003e\u003ctd\u003e\u003cb\u003eRange\u003c/b\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd\u003e*\u003c/td\u003e\u003ctd\u003ein the past six months\u003c/td\u003e\u003ctd\u003eoccurrence within the range is equivalent to \u0027in the past six months\u0027\u003c/td\u003e\u003ctd\u003e-6-0 months\u003c/td\u003e\u003c/tr\u003e\u003c/table\u003e\u003c/blockquote\u003e\u003cblockquote\u003e\u003cp\u003e\u003cb\u003echaracteristic\u003c/b\u003e\u003c/p\u003e\u003cp\u003e\u003cb\u003edescription\u003c/b\u003e: Current evidence of congestive heart failure, angina pectoris, or symptomatic peripheral vascular disease.\u003c/p\u003e\u003cp\u003e\u003cb\u003enote\u003c/b\u003e: This may be possible to encode as presence of Disease(disorder) without \u0027in remission\u0027, placeholder for now to represent \u0027screened surgical candidate\u0027\u003c/p\u003e\u003cp\u003e\u003cb\u003eexclude\u003c/b\u003e: true\u003c/p\u003e\u003cp\u003e\u003cb\u003edefinitionCodeableConcept\u003c/b\u003e: Current evidence of congestive heart failure, angina pectoris, or symptomatic peripheral vascular disease. \u003cspan style\u003d\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"\u003e ()\u003c/span\u003e\u003c/p\u003e\u003c/blockquote\u003e\u003cblockquote\u003e\u003cp\u003e\u003cb\u003echaracteristic\u003c/b\u003e\u003c/p\u003e\u003cp\u003e\u003cb\u003edescription\u003c/b\u003e: Cardiac stress test indicating that surgery or IMM would not be safe.\u003c/p\u003e\u003cp\u003e\u003cb\u003enote\u003c/b\u003e: placeholder for now to represent \u0027screened surgical candidate\u0027\u003c/p\u003e\u003cp\u003e\u003cb\u003eexclude\u003c/b\u003e: true\u003c/p\u003e\u003cp\u003e\u003cb\u003edefinitionCodeableConcept\u003c/b\u003e: Cardiac stress test indicating that surgery or IMM would not be safe. \u003cspan style\u003d\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"\u003e ()\u003c/span\u003e\u003c/p\u003e\u003c/blockquote\u003e\u003cblockquote\u003e\u003cp\u003e\u003cb\u003echaracteristic\u003c/b\u003e\u003c/p\u003e\u003cp\u003e\u003cb\u003edescription\u003c/b\u003e: Pulmonary embolus in the past six months.\u003c/p\u003e\u003cp\u003e\u003cb\u003enote\u003c/b\u003e: placeholder for now to represent \u0027screened surgical candidate\u0027\u003c/p\u003e\u003cp\u003e\u003cb\u003eexclude\u003c/b\u003e: true\u003c/p\u003e\u003ch3\u003eDefinitionByTypeAndValues\u003c/h3\u003e\u003ctable class\u003d\"grid\"\u003e\u003ctr\u003e\u003ctd\u003e-\u003c/td\u003e\u003ctd\u003e\u003cb\u003eType\u003c/b\u003e\u003c/td\u003e\u003ctd\u003e\u003cb\u003eValue[x]\u003c/b\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd\u003e*\u003c/td\u003e\u003ctd\u003eDisease (disorder) \u003cspan style\u003d\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"\u003e (\u003ca href\u003d\"https://browser.ihtsdotools.org/\"\u003eSNOMED CT\u003c/a\u003e#64572001; resource-types#Condition \u0026quot;Condition\u0026quot;)\u003c/span\u003e\u003c/td\u003e\u003ctd\u003ePulmonary embolism (disorder) \u003cspan style\u003d\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"\u003e (\u003ca href\u003d\"https://browser.ihtsdotools.org/\"\u003eSNOMED CT\u003c/a\u003e#59282003)\u003c/span\u003e\u003c/td\u003e\u003c/tr\u003e\u003c/table\u003e\u003ch3\u003eTimeFromEvents\u003c/h3\u003e\u003ctable class\u003d\"grid\"\u003e\u003ctr\u003e\u003ctd\u003e-\u003c/td\u003e\u003ctd\u003e\u003cb\u003eDescription\u003c/b\u003e\u003c/td\u003e\u003ctd\u003e\u003cb\u003eNote\u003c/b\u003e\u003c/td\u003e\u003ctd\u003e\u003cb\u003eRange\u003c/b\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd\u003e*\u003c/td\u003e\u003ctd\u003ein the past six months\u003c/td\u003e\u003ctd\u003eoccurrence within the range is equivalent to \u0027in the past six months\u0027\u003c/td\u003e\u003ctd\u003e-6-0 months\u003c/td\u003e\u003c/tr\u003e\u003c/table\u003e\u003c/blockquote\u003e\u003cblockquote\u003e\u003cp\u003e\u003cb\u003echaracteristic\u003c/b\u003e\u003c/p\u003e\u003cp\u003e\u003cb\u003edescription\u003c/b\u003e: Thrombophlebitis in the past six months.\u003c/p\u003e\u003cp\u003e\u003cb\u003enote\u003c/b\u003e: placeholder for now to represent \u0027screened surgical candidate\u0027\u003c/p\u003e\u003cp\u003e\u003cb\u003eexclude\u003c/b\u003e: true\u003c/p\u003e\u003ch3\u003eDefinitionByTypeAndValues\u003c/h3\u003e\u003ctable class\u003d\"grid\"\u003e\u003ctr\u003e\u003ctd\u003e-\u003c/td\u003e\u003ctd\u003e\u003cb\u003eType\u003c/b\u003e\u003c/td\u003e\u003ctd\u003e\u003cb\u003eValue[x]\u003c/b\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd\u003e*\u003c/td\u003e\u003ctd\u003eDisease (disorder) \u003cspan style\u003d\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"\u003e (\u003ca href\u003d\"https://browser.ihtsdotools.org/\"\u003eSNOMED CT\u003c/a\u003e#64572001; resource-types#Condition \u0026quot;Condition\u0026quot;)\u003c/span\u003e\u003c/td\u003e\u003ctd\u003eThrombophlebitis (disorder) \u003cspan style\u003d\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"\u003e (\u003ca href\u003d\"https://browser.ihtsdotools.org/\"\u003eSNOMED CT\u003c/a\u003e#64156001)\u003c/span\u003e\u003c/td\u003e\u003c/tr\u003e\u003c/table\u003e\u003ch3\u003eTimeFromEvents\u003c/h3\u003e\u003ctable class\u003d\"grid\"\u003e\u003ctr\u003e\u003ctd\u003e-\u003c/td\u003e\u003ctd\u003e\u003cb\u003eDescription\u003c/b\u003e\u003c/td\u003e\u003ctd\u003e\u003cb\u003eNote\u003c/b\u003e\u003c/td\u003e\u003ctd\u003e\u003cb\u003eRange\u003c/b\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd\u003e*\u003c/td\u003e\u003ctd\u003ein the past six months\u003c/td\u003e\u003ctd\u003eoccurrence within the range is equivalent to \u0027in the past six months\u0027\u003c/td\u003e\u003ctd\u003e-6-0 months\u003c/td\u003e\u003c/tr\u003e\u003c/table\u003e\u003c/blockquote\u003e\u003cblockquote\u003e\u003cp\u003e\u003cb\u003echaracteristic\u003c/b\u003e\u003c/p\u003e\u003cp\u003e\u003cb\u003edescription\u003c/b\u003e: Cancer of any kind (except basal cell skin cancer or cancer in situ) unless documented to be disease-free for five years.\u003c/p\u003e\u003cp\u003e\u003cb\u003enote\u003c/b\u003e: This combination logic fails if the patient has both a basal cell skin cancer or cancer in situ and a cancer of another kind., placeholder for now to represent \u0027screened surgical candidate\u0027\u003c/p\u003e\u003cp\u003e\u003cb\u003eexclude\u003c/b\u003e: true\u003c/p\u003e\u003cblockquote\u003e\u003cp\u003e\u003cb\u003edefinitionByCombination\u003c/b\u003e\u003c/p\u003e\u003cp\u003e\u003cb\u003ecode\u003c/b\u003e: all-of\u003c/p\u003e\u003cblockquote\u003e\u003cp\u003e\u003cb\u003echaracteristic\u003c/b\u003e\u003c/p\u003e\u003cp\u003e\u003cb\u003edescription\u003c/b\u003e: Cancer of any kind\u003c/p\u003e\u003cp\u003e\u003cb\u003eexclude\u003c/b\u003e: false\u003c/p\u003e\u003c/blockquote\u003e\u003cblockquote\u003e\u003cp\u003e\u003cb\u003echaracteristic\u003c/b\u003e\u003c/p\u003e\u003cp\u003e\u003cb\u003edescription\u003c/b\u003e: (except basal cell skin cancer)\u003c/p\u003e\u003cp\u003e\u003cb\u003eexclude\u003c/b\u003e: true\u003c/p\u003e\u003c/blockquote\u003e\u003cblockquote\u003e\u003cp\u003e\u003cb\u003echaracteristic\u003c/b\u003e\u003c/p\u003e\u003cp\u003e\u003cb\u003edescription\u003c/b\u003e: (except cancer in situ)\u003c/p\u003e\u003cp\u003e\u003cb\u003eexclude\u003c/b\u003e: true\u003c/p\u003e\u003c/blockquote\u003e\u003cblockquote\u003e\u003cp\u003e\u003cb\u003echaracteristic\u003c/b\u003e\u003c/p\u003e\u003cp\u003e\u003cb\u003edescription\u003c/b\u003e: unless documented to be disease-free for five years\u003c/p\u003e\u003cp\u003e\u003cb\u003eexclude\u003c/b\u003e: true\u003c/p\u003e\u003cp\u003e\u003cb\u003edefinitionCodeableConcept\u003c/b\u003e: No evidence of cancer found (situation) \u003cspan style\u003d\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"\u003e (\u003ca href\u003d\"https://browser.ihtsdotools.org/\"\u003eSNOMED CT\u003c/a\u003e#395100000)\u003c/span\u003e\u003c/p\u003e\u003c/blockquote\u003e\u003c/blockquote\u003e\u003c/blockquote\u003e\u003cblockquote\u003e\u003cp\u003e\u003cb\u003echaracteristic\u003c/b\u003e\u003c/p\u003e\u003cp\u003e\u003cb\u003edescription\u003c/b\u003e: History of coagulopathy\u003c/p\u003e\u003cp\u003e\u003cb\u003enote\u003c/b\u003e: placeholder for now to represent \u0027screened surgical candidate\u0027\u003c/p\u003e\u003cp\u003e\u003cb\u003eexclude\u003c/b\u003e: true\u003c/p\u003e\u003cp\u003e\u003cb\u003edefinitionCodeableConcept\u003c/b\u003e: history of coagulopathy \u003cspan style\u003d\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"\u003e ()\u003c/span\u003e\u003c/p\u003e\u003c/blockquote\u003e\u003cblockquote\u003e\u003cp\u003e\u003cb\u003echaracteristic\u003c/b\u003e\u003c/p\u003e\u003cp\u003e\u003cb\u003edescription\u003c/b\u003e: Significant anemia (hemoglobin 1.0 g or more below normal range)\u003c/p\u003e\u003cp\u003e\u003cb\u003enote\u003c/b\u003e: placeholder for now to represent \u0027screened surgical candidate\u0027\u003c/p\u003e\u003cp\u003e\u003cb\u003eexclude\u003c/b\u003e: true\u003c/p\u003e\u003ch3\u003eDefinitionByTypeAndValues\u003c/h3\u003e\u003ctable class\u003d\"grid\"\u003e\u003ctr\u003e\u003ctd\u003e-\u003c/td\u003e\u003ctd\u003e\u003cb\u003eType\u003c/b\u003e\u003c/td\u003e\u003ctd\u003e\u003cb\u003eValue[x]\u003c/b\u003e\u003c/td\u003e\u003ctd\u003e\u003cb\u003eOffset\u003c/b\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd\u003e*\u003c/td\u003e\u003ctd\u003eHemoglobin [Mass/volume] in Blood \u003cspan style\u003d\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"\u003e (\u003ca href\u003d\"https://loinc.org/\"\u003eLOINC\u003c/a\u003e#718-7)\u003c/span\u003e\u003c/td\u003e\u003ctd\u003e\u0026lt;\u003d-1 g/dL\u003cspan style\u003d\"background: LightGoldenRodYellow\"\u003e (Details: UCUM code g/dL \u003d \u0027g/dL\u0027)\u003c/span\u003e\u003c/td\u003e\u003ctd\u003eLower Normal Limit \u003cspan style\u003d\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"\u003e (\u003ca href\u003d\"codesystem-characteristic-offset.html\"\u003eCharacteristicOffset\u003c/a\u003e#LNL)\u003c/span\u003e\u003c/td\u003e\u003c/tr\u003e\u003c/table\u003e\u003c/blockquote\u003e\u003cblockquote\u003e\u003cp\u003e\u003cb\u003echaracteristic\u003c/b\u003e\u003c/p\u003e\u003cp\u003e\u003cb\u003edescription\u003c/b\u003e: Serum creatinine ≥ 1.5 mg/dl\u003c/p\u003e\u003cp\u003e\u003cb\u003enote\u003c/b\u003e: placeholder for now to represent \u0027screened surgical candidate\u0027\u003c/p\u003e\u003cp\u003e\u003cb\u003eexclude\u003c/b\u003e: true\u003c/p\u003e\u003ch3\u003eDefinitionByTypeAndValues\u003c/h3\u003e\u003ctable class\u003d\"grid\"\u003e\u003ctr\u003e\u003ctd\u003e-\u003c/td\u003e\u003ctd\u003e\u003cb\u003eType\u003c/b\u003e\u003c/td\u003e\u003ctd\u003e\u003cb\u003eValue[x]\u003c/b\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd\u003e*\u003c/td\u003e\u003ctd\u003eCreatinine [Mass/volume] in Serum or Plasma \u003cspan style\u003d\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"\u003e (\u003ca href\u003d\"https://loinc.org/\"\u003eLOINC\u003c/a\u003e#2160-0)\u003c/span\u003e\u003c/td\u003e\u003ctd\u003e\u0026gt;\u003d1.5 mg/dl\u003cspan style\u003d\"background: LightGoldenRodYellow\"\u003e (Details: UCUM code mg/dL \u003d \u0027mg/dL\u0027)\u003c/span\u003e\u003c/td\u003e\u003c/tr\u003e\u003c/table\u003e\u003c/blockquote\u003e\u003c/div\u003e"},"identifier":[{"type":{"text":"FEvIR Object Identifier"},"system":"https://fevir.net","value":"32140","assigner":{"display":"Computable Publishing LLC"}}],"title":"RecommendationEligibilityCriteria: Eligibility Criteria for Bariatric Surgery (ADA Recommendation 8.16)","shortTitle":"Recommend bariatric surgery if BMI 35 or higher","status":"active","publisher":"Computable Publishing LLC","contact":[{"telecom":[{"system":"email","value":"support@computablepublishing.com"}]}],"description":"Inclusion Criteria: [[1]] Adults. [[2]] Diagnosed with type 2 diabetes. [[3]] Body Mass Index (BMI) ≥ 40.0 kg/m2 (BMI ≥ 37.5 kg/m2 in Asian Americans), or BMI ≥ 35.0 kg/m2 and ≤ 39.9 kg/m2 (BMI 32.5-37.4 kg/m2 in Asian Americans) who do not achieve durable weight loss and improvement in comorbidities (including hyperglycemia) with nonsurgical methods. [[4]] Screened surgical candidates.","copyright":"https://creativecommons.org/licenses/by-nc-sa/4.0/","effectivePeriod":{"start":"2021-01"},"author":[{"name":"Brian S. Alper"}],"actual":false,"characteristic":[{"description":"Adult.","exclude":false,"definitionByTypeAndValue":{"type":{"coding":[{"system":"http://snomed.info/sct","code":"397669002","display":"Age"}]},"valueQuantity":{"value":18,"comparator":"\u003e\u003d","unit":"years","system":"http://unitsofmeasure.org","code":"a"}}},{"description":"Diagnosed with type 2 diabetes.","exclude":false,"definitionByTypeAndValue":{"type":{"coding":[{"system":"http://snomed.info/sct","code":"64572001","display":"Disease (disorder)"},{"system":"http://hl7.org/fhir/resource-types","code":"Condition","display":"Condition"}]},"valueCodeableConcept":{"coding":[{"system":"http://snomed.info/sct","code":"44054006","display":"Diabetes mellitus type 2 (disorder)"}]}}},{"description":"Body Mass Index (BMI) ≥ 40.0 kg/m2 (BMI ≥ 37.5 kg/m2 in Asian Americans), or BMI ≥ 35.0 kg/m2 and ≤ 39.9 kg/m2 (BMI 32.5-37.4 kg/m2 in Asian Americans) who do not achieve durable weight loss and improvement in comorbidities (including hyperglycemia) with nonsurgical methods.","definitionByCombination":{"code":"any-of","characteristic":[{"description":"Body Mass Index (BMI) ≥ 40.0 kg/m2","exclude":false,"definitionByTypeAndValue":{"type":{"coding":[{"system":"http://loinc.org","code":"39156-5","display":"Body mass index (BMI) [Ratio]"}]},"valueQuantity":{"value":40,"comparator":"\u003e\u003d","unit":"kg/m2","system":"http://unitsofmeasure.org","code":"kg/m2"}}},{"description":"BMI ≥ 37.5 kg/m2 in Asian Americans","definitionByCombination":{"code":"all-of","characteristic":[{"description":"BMI ≥ 37.5 kg/m2","exclude":false,"definitionByTypeAndValue":{"type":{"coding":[{"system":"http://loinc.org","code":"39156-5","display":"Body mass index (BMI) [Ratio]"}]},"valueQuantity":{"value":37.5,"comparator":"\u003e\u003d","unit":"kg/m2","system":"http://unitsofmeasure.org","code":"kg/m2"}}},{"linkId":"AsianAmerican","description":"Asian American","note":[{"text":"The evidence and guideline panel decision to modify the BMI threshold for Asian Americans is based on data mostly from Asian Americans not generally including Native Hawaiians and other Pacific Islanders, so it is not explicit whether the modified thresholds apply to Native Hawaiians and other Pacific Islanders. See https://diabetesjournals.org/care/article/38/1/150/37769/BMI-Cut-Points-to-Identify-At-Risk-Asian-Americans for details"}],"definitionByTypeAndValue":{"type":{"coding":[{"system":"http://snomed.info/sct","code":"103579009","display":"Race (observable entity)"}]},"valueCodeableConcept":{"coding":[{"system":"urn:oid:2.16.840.1.113883.6.238","code":"2028-9","display":"Asian"}],"text":"Asian American"}}}]}},{"description":"BMI ≥ 35.0 kg/m2 and ≤ 39.9 kg/m2 who do not achieve durable weight loss and improvement in comorbidities (including hyperglycemia) with nonsurgical methods.","definitionByCombination":{"code":"all-of","characteristic":[{"description":"BMI ≥ 35.0 kg/m2 and ≤ 39.9 kg/m2","definitionByTypeAndValue":{"type":{"coding":[{"system":"http://loinc.org","code":"39156-5","display":"Body mass index (BMI) [Ratio]"}]},"valueRange":{"low":{"value":35,"unit":"kg/m2","system":"http://unitsofmeasure.org","code":"kg/m2"},"high":{"value":39.9,"unit":"kg/m2","system":"http://unitsofmeasure.org","code":"kg/m2"}}}},{"description":"who do not achieve durable weight loss and improvement in comorbidities (including hyperglycemia) with nonsurgical methods.","exclude":true,"definitionCodeableConcept":{"text":"achieving durable weight loss and improvement in comorbidities (including hyperglycemia) with nonsurgical methods"}}]}},{"description":"BMI ≥ 32.5 kg/m2 and ≤ 37.4 kg/m2 in Asian Americans who do not achieve durable weight loss and improvement in comorbidities (including hyperglycemia) with nonsurgical methods.","definitionByCombination":{"code":"all-of","characteristic":[{"description":"BMI ≥ 32.5 kg/m2 and ≤ 37.4 kg/m2","definitionByTypeAndValue":{"type":{"coding":[{"system":"http://loinc.org","code":"39156-5","display":"Body mass index (BMI) [Ratio]"}]},"valueRange":{"low":{"value":32.5,"unit":"kg/m2","system":"http://unitsofmeasure.org","code":"kg/m2"},"high":{"value":37.4,"unit":"kg/m2","system":"http://unitsofmeasure.org","code":"kg/m2"}}}},{"description":"Asian American","definitionId":"AsianAmerican"},{"description":"who do not achieve durable weight loss and improvement in comorbidities (including hyperglycemia) with nonsurgical methods.","exclude":true,"definitionCodeableConcept":{"text":"achieving durable weight loss and improvement in comorbidities (including hyperglycemia) with nonsurgical methods"}}]}}]}},{"description":"Cardiovascular event (myocardial infarction, acute coronary syndrome, coronary artery angioplasty or bypass, stroke) in the past six months.","note":[{"text":"placeholder for now to represent \u0027screened surgical candidate\u0027"}],"exclude":true,"definitionByCombination":{"code":"any-of","characteristic":[{"description":"acute coronary heart disease (a value set covering many forms)","definitionByTypeAndValue":{"type":{"coding":[{"system":"http://snomed.info/sct","code":"64572001","display":"Disease (disorder)"},{"system":"http://hl7.org/fhir/resource-types","code":"Condition","display":"Condition"}]},"valueReference":{"reference":"ValueSet/32152","type":"ValueSet","display":"Acute Coronary Heart Disease Value Set"}}},{"description":"coronary artery angioplasty or bypass","definitionByTypeAndValue":{"type":{"coding":[{"system":"http://snomed.info/sct","code":"71388002","display":"Procedure (procedure)"},{"system":"http://hl7.org/fhir/resource-types","code":"Procedure","display":"Procedure"}]},"valueCodeableConcept":{"coding":[{"system":"http://snomed.info/sct","code":"81266008","display":"Heart revascularization (procedure)"}]}}},{"description":"stroke","definitionByTypeAndValue":{"type":{"coding":[{"system":"http://snomed.info/sct","code":"64572001","display":"Disease (disorder)"},{"system":"http://hl7.org/fhir/resource-types","code":"Condition","display":"Condition"}]},"valueCodeableConcept":{"coding":[{"system":"http://snomed.info/sct","code":"230690007","display":"Cerebrovascular accident (disorder)"}]}}}]},"timeFromEvent":[{"description":"in the past six months","note":[{"text":"occurrence within the range is equivalent to \u0027in the past six months\u0027"}],"range":{"low":{"value":-6,"unit":"months","system":"http://unitsofmeasure.org","code":"mo"},"high":{"value":0,"unit":"months","system":"http://unitsofmeasure.org","code":"mo"}}}]},{"description":"Current evidence of congestive heart failure, angina pectoris, or symptomatic peripheral vascular disease.","note":[{"text":"This may be possible to encode as presence of Disease(disorder) without \u0027in remission\u0027"},{"text":"placeholder for now to represent \u0027screened surgical candidate\u0027"}],"exclude":true,"definitionCodeableConcept":{"text":"Current evidence of congestive heart failure, angina pectoris, or symptomatic peripheral vascular disease."}},{"description":"Cardiac stress test indicating that surgery or IMM would not be safe.","note":[{"text":"placeholder for now to represent \u0027screened surgical candidate\u0027"}],"exclude":true,"definitionCodeableConcept":{"text":"Cardiac stress test indicating that surgery or IMM would not be safe."}},{"description":"Pulmonary embolus in the past six months.","note":[{"text":"placeholder for now to represent \u0027screened surgical candidate\u0027"}],"exclude":true,"definitionByTypeAndValue":{"type":{"coding":[{"system":"http://snomed.info/sct","code":"64572001","display":"Disease (disorder)"},{"system":"http://hl7.org/fhir/resource-types","code":"Condition","display":"Condition"}]},"valueCodeableConcept":{"coding":[{"system":"http://snomed.info/sct","code":"59282003","display":"Pulmonary embolism (disorder)"}]}},"timeFromEvent":[{"description":"in the past six months","note":[{"text":"occurrence within the range is equivalent to \u0027in the past six months\u0027"}],"range":{"low":{"value":-6,"unit":"months","system":"http://unitsofmeasure.org","code":"mo"},"high":{"value":0,"unit":"months","system":"http://unitsofmeasure.org","code":"mo"}}}]},{"description":"Thrombophlebitis in the past six months.","note":[{"text":"placeholder for now to represent \u0027screened surgical candidate\u0027"}],"exclude":true,"definitionByTypeAndValue":{"type":{"coding":[{"system":"http://snomed.info/sct","code":"64572001","display":"Disease (disorder)"},{"system":"http://hl7.org/fhir/resource-types","code":"Condition","display":"Condition"}]},"valueCodeableConcept":{"coding":[{"system":"http://snomed.info/sct","code":"64156001","display":"Thrombophlebitis (disorder)"}]}},"timeFromEvent":[{"description":"in the past six months","note":[{"text":"occurrence within the range is equivalent to \u0027in the past six months\u0027"}],"range":{"low":{"value":-6,"unit":"months","system":"http://unitsofmeasure.org","code":"mo"},"high":{"value":0,"unit":"months","system":"http://unitsofmeasure.org","code":"mo"}}}]},{"description":"Cancer of any kind (except basal cell skin cancer or cancer in situ) unless documented to be disease-free for five years.","note":[{"text":"This combination logic fails if the patient has both a basal cell skin cancer or cancer in situ and a cancer of another kind."},{"text":"placeholder for now to represent \u0027screened surgical candidate\u0027"}],"exclude":true,"definitionByCombination":{"code":"all-of","characteristic":[{"description":"Cancer of any kind","exclude":false,"definitionByTypeAndValue":{"type":{"coding":[{"system":"http://snomed.info/sct","code":"64572001","display":"Disease (disorder)"},{"system":"http://hl7.org/fhir/resource-types","code":"Condition","display":"Condition"}]},"valueCodeableConcept":{"coding":[{"system":"http://snomed.info/sct","code":"363346000","display":"Malignant neoplastic disease (disorder)"}]}}},{"description":"(except basal cell skin cancer)","exclude":true,"definitionByTypeAndValue":{"type":{"coding":[{"system":"http://snomed.info/sct","code":"64572001","display":"Disease (disorder)"},{"system":"http://hl7.org/fhir/resource-types","code":"Condition","display":"Condition"}]},"valueCodeableConcept":{"coding":[{"system":"http://snomed.info/sct","code":"254701007","display":"Basal cell carcinoma of skin (disorder)"}]}}},{"description":"(except cancer in situ)","exclude":true,"definitionByTypeAndValue":{"type":{"coding":[{"system":"http://snomed.info/sct","code":"64572001","display":"Disease (disorder)"},{"system":"http://hl7.org/fhir/resource-types","code":"Condition","display":"Condition"}]},"valueCodeableConcept":{"coding":[{"system":"http://snomed.info/sct","code":"109355002","display":"Carcinoma in situ (disorder)"}]}}},{"description":"unless documented to be disease-free for five years","exclude":true,"definitionCodeableConcept":{"coding":[{"system":"http://snomed.info/sct","code":"395100000","display":"No evidence of cancer found (situation)"}]},"timeFromEvent":[{"description":"for five years","note":[{"text":"presence throughout the range is equivalent to \u0027for five years\u0027"}],"range":{"low":{"value":-5,"unit":"years","system":"http://unitsofmeasure.org","code":"a"},"high":{"value":0,"unit":"years","system":"http://unitsofmeasure.org","code":"a"}}}]}]}},{"description":"History of coagulopathy","note":[{"text":"placeholder for now to represent \u0027screened surgical candidate\u0027"}],"exclude":true,"definitionCodeableConcept":{"text":"history of coagulopathy"}},{"description":"Significant anemia (hemoglobin 1.0 g or more below normal range)","note":[{"text":"placeholder for now to represent \u0027screened surgical candidate\u0027"}],"exclude":true,"definitionByTypeAndValue":{"type":{"coding":[{"system":"http://loinc.org","code":"718-7","display":"Hemoglobin [Mass/volume] in Blood"}]},"valueQuantity":{"value":-1,"comparator":"\u003c\u003d","unit":"g/dL","system":"http://unitsofmeasure.org","code":"g/dL"},"offset":{"coding":[{"system":"http://hl7.org/fhir/characteristic-offset","code":"LNL","display":"Lower Normal Limit"}]}}},{"description":"Serum creatinine ≥ 1.5 mg/dl","note":[{"text":"placeholder for now to represent \u0027screened surgical candidate\u0027"}],"exclude":true,"definitionByTypeAndValue":{"type":{"coding":[{"system":"http://loinc.org","code":"2160-0","display":"Creatinine [Mass/volume] in Serum or Plasma"}]},"valueQuantity":{"value":1.5,"comparator":"\u003e\u003d","unit":"mg/dl","system":"http://unitsofmeasure.org","code":"mg/dL"}}}]}